Alumis, Inc. (ALMS)
22.36
-0.85
(-3.66%)
USD |
NASDAQ |
Aug 28, 16:00
22.36
0.00 (0.00%)
After-Hours: 20:00
Alumis Free Cash Flow : -351.80M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -351.80M |
| March 31, 2026 | -377.03M |
| December 31, 2025 | -370.18M |
| September 30, 2025 | -373.40M |
| June 30, 2025 | -347.04M |
| March 31, 2025 | -292.78M |
| Date | Value |
|---|---|
| December 31, 2024 | -256.81M |
| September 30, 2024 | -216.62M |
| June 30, 2024 | -167.49M |
| March 31, 2024 | -143.93M |
| December 31, 2023 | -134.47M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Corcept Therapeutics, Inc. | 106.92M |
| Aclaris Therapeutics, Inc. | -61.34M |
| Crinetics Pharmaceuticals, Inc. | -425.18M |
| Tarsus Pharmaceuticals, Inc. | 56.00M |
| Structure Therapeutics, Inc. | -225.05M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -81.50M |
| Cash from Investing (Quarterly) | 68.69M |
| Cash from Financing (Quarterly) | 12.63M |
| Free Cash Flow Per Share (Quarterly) | -0.6401 |
| Free Cash Flow to Equity (Quarterly) | -82.50M |
| Free Cash Flow to Firm (Quarterly) | -81.74M |
| Free Cash Flow Yield | -13.64% |